Mia's Feed
Medical News & Research

Innovative App Supports Caregivers of Bone Marrow Transplant Patients

Innovative App Supports Caregivers of Bone Marrow Transplant Patients

Share this article

A groundbreaking app developed by Mass General Brigham has demonstrated significant benefits in improving quality of life and reducing caregiver burden for those caring for bone marrow transplant patients. Clinical trials show promising results, with the app offering accessible psychological support during the transplant journey.

2 min read

A recent study conducted by researchers at Mass General Brigham introduces a new digital application designed to enhance the quality of life for caregivers of patients undergoing bone marrow transplants (BMT). In a randomized clinical trial, caregivers who utilized this app experienced notable improvements in their overall well-being, including reduced feelings of burden, better mood, and higher quality of life, compared to those who relied solely on standard supportive care services. These findings were shared at the American Society of Clinical Oncology annual meeting and published in the Journal of Clinical Oncology.

Caregivers of BMT patients often face high rates of depression and anxiety, with the demanding nature of caregiving impacting their employment, household roles, and personal lives. Recognizing these challenges, co-developer Dr. Jamie Jacobs from Mass General Brigham highlighted that the new app aims to provide accessible support to alleviate their burden. The app was developed alongside Dr. Areej El-Jawahri and features educational modules, interactive games, and videos based on evidence-based psychological strategies. It guides caregivers through each phase of the transplant process—before, during, and after—offering tailored resources.

The clinical trial involved 125 caregivers, half of whom received the app in addition to usual care. On average, participants spent over two hours engaging with the app. Results indicated that app users reported better quality of life, less caregiving burden, and fewer symptoms of depression and PTSD at 60 days post-transplant. Dr. Jacobs emphasized that the app could serve as a vital resource for caregivers who might lack the time, money, or energy to access traditional mental health services.

The research team plans to expand testing of the BMT-CARE app across multiple centers and diverse caregiver populations, aiming to provide scalable, evidence-based support for those caring for BMT patients. This innovative digital tool represents a significant step toward improving caregiver well-being amidst complex medical treatments.

source: https://medicalxpress.com/news/2025-05-app-caregivers-people-bone-marrow.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Many Americans Unaware That High Blood Pressure Often Has No Noticeable Symptoms

A recent survey reveals that most Americans are unaware that high blood pressure often has no noticeable symptoms, underlining the need for increased awareness and regular monitoring to prevent serious health complications.

Why Increasing Diversity Among Organ Donors Is Essential for Transplant Success

Increasing diversity among organ donors is key to saving more lives and improving transplant success rates, especially for minority communities disproportionately affected by organ failure.

New Research Links Gabapentin Use to Higher Dementia and Cognitive Impairment Risks

Recent research indicates that frequent gabapentin use for chronic pain may significantly elevate the risk of dementia and cognitive impairment, especially among younger adults. Learn more about these vital findings.

Reforming PBM Payment Structures Could Significantly Reduce Prescription Drug Costs

Reforming pharmacy benefit manager compensation by unlinking it from drug list prices could generate billions in savings and promote a fairer, more transparent prescription drug market.